US86333M1080 - Common Stock

**LRN** gets a fundamental rating of **7** out of 10. The analysis compared the fundamentals against 66 industry peers in the **Diversified Consumer Services** industry. **LRN** has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. **LRN** is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes **LRN** very considerable for growth and quality investing!

In the past year **LRN** was profitable.

In the past 5 years **LRN** has always been profitable.

In the past 5 years **LRN** always reported a positive cash flow from operatings.

Looking at the **Return On Invested Capital**, with a value of **11.14%**, **LRN** belongs to the top of the industry, outperforming **85.94%** of the companies in the same industry.

The last **Return On Invested Capital** (**11.14%**) for **LRN** is above the 3 year average (**9.47%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 10.63% | ||

ROE | 17.36% | ||

ROIC | 11.14% |

ROA(3y)8.12%

ROA(5y)6.23%

ROE(3y)14.65%

ROE(5y)11.29%

ROIC(3y)9.47%

ROIC(5y)7.52%

The **Profit Margin** of **LRN** (**10.01%**) is better than **78.13%** of its industry peers.

The **Operating Margin** of **LRN** (**12.23%**) is better than **75.00%** of its industry peers.

In the last couple of years the **Operating Margin** of **LRN** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 12.23% | ||

PM (TTM) | 10.01% | ||

GM | 37.43% |

OM growth 3Y19.4%

OM growth 5Y22.26%

PM growth 3Y29.12%

PM growth 5Y22.27%

GM growth 3Y2.45%

GM growth 5Y1.54%

Compared to 1 year ago, **LRN** has more shares outstanding

The debt/assets ratio for **LRN** has been reduced compared to a year ago.

The **Debt to Equity ratio** of **LRN** (**0.38**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.38 | ||

Debt/FCF | 2.17 | ||

Altman-Z | 5.25 |

ROIC/WACC1.44

WACC7.75%

The **Current ratio** of **LRN** (**5.10**) is better than **89.06%** of its industry peers.

A Quick Ratio of **4.95** indicates that **LRN** has no problem at all paying its short term obligations.

The **Quick ratio** of **LRN** (**4.95**) is better than **89.06%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 5.1 | ||

Quick Ratio | 4.95 |

The **Earnings Per Share** has grown by an impressive **57.77%** over the past year.

Measured over the past years, **LRN** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **39.31%** on average per year.

The **Revenue** has grown by **11.03%** in the past year. This is quite good.

EPS 1Y (TTM)57.77%

EPS 3Y39.51%

EPS 5Y39.31%

EPS Q2Q%40.59%

Revenue 1Y (TTM)11.03%

Revenue growth 3Y9.9%

Revenue growth 5Y14.97%

Sales Q2Q%10.49%

Based on estimates for the next years, **LRN** will show a quite strong growth in **Revenue**. The Revenue will grow by **8.52%** on average per year.

EPS Next Y7.48%

EPS Next 2Y10.8%

EPS Next 3Y12.65%

EPS Next 5YN/A

Revenue Next Year6.77%

Revenue Next 2Y7.19%

Revenue Next 3Y8.52%

Revenue Next 5YN/A

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

With a **Price/Earnings** ratio of **16.49**, **LRN** is valued correctly.

Based on the **Price/Earnings** ratio, **LRN** is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.

With a **Price/Forward Earnings** ratio of **15.35**, **LRN** is valued correctly.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **LRN** indicates a somewhat cheap valuation: **LRN** is cheaper than 76.56% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.49 | ||

Fwd PE | 15.35 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **LRN** indicates a rather cheap valuation: **LRN** is cheaper than 81.25% of the companies listed in the same industry.

71.88% of the companies in the same industry are more expensive than **LRN**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.35 | ||

EV/EBITDA | 8.28 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

A more expensive valuation may be justified as **LRN**'s earnings are expected to grow with **12.65%** in the coming years.

PEG (NY)2.21

PEG (5Y)0.42

EPS Next 2Y10.8%

EPS Next 3Y12.65%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**STRIDE INC**

NYSE:LRN (10/8/2024, 5:05:32 PM)

After market: 77.02 0 (0%)**77.02**

**-1.26 (-1.61%) **

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryDiversified Consumer Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.33B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.49 | ||

Fwd PE | 15.35 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)2.21

PEG (5Y)0.42

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 10.63% | ||

ROE | 17.36% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 12.23% | ||

PM (TTM) | 10.01% | ||

GM | 37.43% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.06

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.38 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 5.1 | ||

Quick Ratio | 4.95 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)57.77%

EPS 3Y39.51%

EPS 5Y

EPS Q2Q%

EPS Next Y7.48%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)11.03%

Revenue growth 3Y9.9%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y